Privia Health Group, Inc.

Informe acción NasdaqGS:PRVA

Capitalización de mercado: US$2.6b

Privia Health Group Dirección

Dirección controles de criterios 2/4

El CEO de Privia Health Group es Parth Mehrotra , nombrado en Jul 2023, tiene una permanencia de 1.33 años. compensación anual total es $17.07M, compuesta por 3.2% salario y 96.8% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.13% de las acciones de la empresa, por valor de $3.31M. La antigüedad media del equipo directivo y de la junta directiva es de 5.4 años y 3 años, respectivamente.

Información clave

Parth Mehrotra

Chief Executive Officer (CEO)

US$17.1m

Compensación total

Porcentaje del salario del CEO3.2%
Permanencia del CEO1.3yrs
Participación del CEO0.1%
Permanencia media de la dirección5.4yrs
Promedio de permanencia en la Junta Directiva3yrs

Actualizaciones recientes de la dirección

Recent updates

After Leaping 32% Privia Health Group, Inc. (NASDAQ:PRVA) Shares Are Not Flying Under The Radar

Nov 08
After Leaping 32% Privia Health Group, Inc. (NASDAQ:PRVA) Shares Are Not Flying Under The Radar

There Are Reasons To Feel Uneasy About Privia Health Group's (NASDAQ:PRVA) Returns On Capital

Nov 04
There Are Reasons To Feel Uneasy About Privia Health Group's (NASDAQ:PRVA) Returns On Capital

It's A Story Of Risk Vs Reward With Privia Health Group, Inc. (NASDAQ:PRVA)

Sep 12
It's A Story Of Risk Vs Reward With Privia Health Group, Inc. (NASDAQ:PRVA)

There May Be Reason For Hope In Privia Health Group's (NASDAQ:PRVA) Disappointing Earnings

Aug 16
There May Be Reason For Hope In Privia Health Group's (NASDAQ:PRVA) Disappointing Earnings

Some Investors May Be Worried About Privia Health Group's (NASDAQ:PRVA) Returns On Capital

Jul 12
Some Investors May Be Worried About Privia Health Group's (NASDAQ:PRVA) Returns On Capital

Privia Health Group, Inc.'s (NASDAQ:PRVA) Subdued P/S Might Signal An Opportunity

Jun 11
Privia Health Group, Inc.'s (NASDAQ:PRVA) Subdued P/S Might Signal An Opportunity

Privia Health: Key Lessons Learned (Rating Downgrade)

May 22

Analysts Just Slashed Their Privia Health Group, Inc. (NASDAQ:PRVA) EPS Numbers

Mar 03
Analysts Just Slashed Their Privia Health Group, Inc. (NASDAQ:PRVA) EPS Numbers

The Price Is Right For Privia Health Group, Inc. (NASDAQ:PRVA)

Feb 27
The Price Is Right For Privia Health Group, Inc. (NASDAQ:PRVA)

There Are Reasons To Feel Uneasy About Privia Health Group's (NASDAQ:PRVA) Returns On Capital

Jan 31
There Are Reasons To Feel Uneasy About Privia Health Group's (NASDAQ:PRVA) Returns On Capital

Why Privia Health Group, Inc. (NASDAQ:PRVA) Could Be Worth Watching

Dec 03
Why Privia Health Group, Inc. (NASDAQ:PRVA) Could Be Worth Watching

Privia Health Group, Inc.'s (NASDAQ:PRVA) Price In Tune With Revenues

Nov 06
Privia Health Group, Inc.'s (NASDAQ:PRVA) Price In Tune With Revenues

Privia Health Group's (NASDAQ:PRVA) Returns On Capital Not Reflecting Well On The Business

Aug 08
Privia Health Group's (NASDAQ:PRVA) Returns On Capital Not Reflecting Well On The Business

Privia Health Group, Inc. (NASDAQ:PRVA) Shares Could Be 48% Below Their Intrinsic Value Estimate

Mar 17
Privia Health Group, Inc. (NASDAQ:PRVA) Shares Could Be 48% Below Their Intrinsic Value Estimate

Privia Health: In Line For Solid FY22, Hold On Valuation

Sep 15

Privia Health Group reports Q2 earnings beat; raises FY22 outlook

Aug 11

Privia Health Group Grows But Operating Results Await

Jun 20

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Parth Mehrotra en comparación con los beneficios de Privia Health Group?
FechaCompensación totalSalarioIngresos de la empresa
Sep 30 2024n/an/a

US$13m

Jun 30 2024n/an/a

US$15m

Mar 31 2024n/an/a

US$19m

Dec 31 2023US$17mUS$542k

US$23m

Sep 30 2023n/an/a

US$38m

Jun 30 2023n/an/a

US$34m

Mar 31 2023n/an/a

US$16m

Dec 31 2022US$1mUS$475k

-US$9m

Sep 30 2022n/an/a

-US$38m

Jun 30 2022n/an/a

-US$49m

Mar 31 2022n/an/a

-US$211m

Dec 31 2021US$52mUS$475k

-US$188m

Sep 30 2021n/an/a

-US$172m

Jun 30 2021n/an/a

-US$147m

Mar 31 2021n/an/a

US$31m

Dec 31 2020US$1mUS$412k

US$31m

Compensación vs. Mercado: La compensación total de Parth($USD17.07M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD6.54M).

Compensación vs. Ingresos: La compensación de Parth ha aumentado más de un 20%, mientras que los beneficios de la empresa han caído más de un 20% en el último año.


CEO

Parth Mehrotra (45 yo)

1.3yrs

Permanencia

US$17,073,185

Compensación

Mr. Parth Mehrotra serves as Chief Executive Officer and Director of Privia Health Group, Inc. since July 1, 2023. He had been the President and Chief Operating Officer of Privia Health Group, Inc. since 2...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Parth Mehrotra
CEO & Director1.3yrsUS$17.07m0.13%
$ 3.3m
David Mountcastle
Executive VP2.7yrsUS$2.32m0.22%
$ 5.7m
Sarath Degala
Chief Operating Officerless than a yearsin datossin datos
Chris Voigt
Executive VP & Chief Technology Officer8.6yrssin datossin datos
Robert Borchert
Senior Vice President of Investor Relations & Corporate Communicationsno datasin datossin datos
Dana Fields
Chief Audit & Compliance Officer5.4yrssin datossin datos
Edward Fargis
Executive VPless than a yearsin datossin datos
Jenny Harding
Chief People Officer8.3yrssin datossin datos
Jay Stevens
Senior VP & Chief Growth Officerno datasin datossin datos
Eric Beyer
Executive Vice President of Medical Groups8.8yrssin datossin datos
Keith Fernandez
Executive VP & Chief Clinical Officer7yrssin datossin datos
Fred Taweel
Chairman of the Board of Governorsno datasin datossin datos

5.4yrs

Permanencia media

Equipo directivo experimentado: El equipo directivo de PRVA es experimentado (5.4 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Parth Mehrotra
CEO & Director1.3yrsUS$17.07m0.13%
$ 3.3m
Nancy Cocozza
Independent Director2.6yrsUS$275.06k0.0059%
$ 152.4k
David Wichmann
Independent Director1.3yrsUS$202.69k0.0052%
$ 133.5k
Adam Boehler
Independent Director1.3yrssin datos4.81%
$ 124.5m
Patricia Maryland
Independent Director3.6yrsUS$290.06k0.013%
$ 324.2k
David King
Independent Chairman3.8yrsUS$335.06k0.013%
$ 324.2k
Pamela Kimmet
Director1.3yrsUS$211.02k0.0052%
$ 133.5k
Matthew Morris
Director6.5yrsUS$679.52k0.045%
$ 1.2m
Thomas McCarthy
Independent Director3.6yrsUS$300.06k0.035%
$ 894.4k
Jaewon Ryu
Independent Director3.4yrsUS$275.06k0.0095%
$ 245.0k

3.0yrs

Permanencia media

62yo

Promedio de edad

Junta con experiencia: La junta directiva de PRVA se considera experimentada (3 años de antigüedad promedio).